Beta-lactamase
Showing 1 - 25 of 3,147
Sepsis, Septic Shock Trial (Piperacillin/tazobactam or temocillin, Meropenem)
Not yet recruiting
- Sepsis
- Septic Shock
- Piperacillin/tazobactam or temocillin
- Meropenem
- (no location specified)
Oct 3, 2022
Extended Spectrum Beta Lactamase Producing Organisms In Urinary
Not yet recruiting
- Urinary Tract Infections
- (no location specified)
Nov 18, 2021
Advancing Age and Mortality at 30 Days in Bacteremia E. Coli
Completed
- Beta-lactamase Extended Spectrum, E. Coli, Elderly, Mortality, Risk Factor
-
Nantes, FranceCHU Nantes
Sep 20, 2021
Developing Microbials to Fight Extended-spectrum
Active, not recruiting
- Extended Spectrum Beta Lactamases (ESBL) E. Coli
- examination of stool sample
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Clinical Microbiology
Aug 3, 2021
Research of Consequences on Digestive Tract Following Proposed
Recruiting
- Urinary Tract Infections
- Urinary Tract Infections in Children
- Amikacin
- usual antibiotic treatment
-
Clamart, Ile-de France, France
- +19 more
Jan 25, 2023
Enterobacteriaceae Infections Trial in Bayonne, Bordeaux (Piperacillin-tazobactam)
Not yet recruiting
- Enterobacteriaceae Infections
-
Bayonne, France
- +1 more
Jun 4, 2021
Neonatal Sepsis Trial in Babati (Labinic (R) probiotic mixture, Placebo)
Not yet recruiting
- Neonatal Sepsis
- Labinic (R) probiotic mixture
- Placebo
-
Babati, Manyara, TanzaniaHaydom Lutheran Hospital
Nov 23, 2020
Urinary Tract Infections Trial in France (Temocillin, meropenem or imipenem)
Completed
- Urinary Tract Infections
- Temocillin
- meropenem or imipenem
-
Fort-de-france, Martinique, France
- +15 more
Apr 16, 2021
Bacteremia Caused by Gram-Negative Bacteria Trial in Worldwide (Ceftolozane-Tazobactam, Meropenem)
Withdrawn
- Bacteremia Caused by Gram-Negative Bacteria
-
Newcastle, New South Wales, Australia
- +28 more
May 17, 2022
Urinary Tract Infection Due to Beta-lactamase-producing
Completed
- Urinary Tract Infections
-
Clamart, Ile-de France, France
- +23 more
Jul 31, 2020
Bloodstream Infections Trial in Australia, Singapore (Meropenem, Piperacillin-tazobactam combination product)
Active, not recruiting
- Bloodstream Infections
- Meropenem
- Piperacillin-tazobactam combination product
-
New Lambton, New South Wales, Australia
- +5 more
Nov 3, 2020
Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant
Terminated
- Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects
- KB109
- No intervention
-
Torrance, California
- +7 more
Jan 20, 2021
Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)
Completed
- Bacterial Infections
- QPX2015
- Placebo oral capsule
-
Adelaide, South Australia, AustraliaCMAX
Oct 6, 2022
ESBL-E Colonisation and Subsequent ESBL-E Infection
Unknown status
- Extended Spectrum Beta-Lactamase Producing Bacteria Infection
- +2 more
- ESBL-E fecal carriage screening according to routine care
-
Bordeaux, Nouvelle-Aquitaine, FranceMedical intensive care unit, Pelelgrin hospital
Oct 17, 2019
Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Canada, Israel
Recruiting
- Beta Lactam Resistant Bacterial Infection
- +2 more
-
Montreal, Quebec, Canada
- +7 more
Jul 25, 2022
Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Israel (Piperacillin / Tazobactam
Recruiting
- Beta Lactam Resistant Bacterial Infection
- +2 more
- Piperacillin / Tazobactam Injection
- Meropenem
-
Haifa, Israel
- +3 more
Jul 25, 2022
Bronchiectasis Trial in Guangzhou (Fluroquinolones, Beta-lactamase inhibitor)
Recruiting
- Bronchiectasis
- Fluroquinolones
- Beta-lactamase inhibitor
-
Guangzhou, Guangdong, ChinaState Key Laboratory of Respiratory Disease, First Affiliated Ho
Feb 8, 2020
Neisseria Gonorrhoeae Infection, Asymptomatic Pharyngeal Carriage Trial (Absence of antibiotic treatment, Ceftriaxone)
Not yet recruiting
- Neisseria Gonorrhoeae Infection
- Asymptomatic Pharyngeal Carriage
- Absence of antibiotic treatment
- Ceftriaxone
- (no location specified)
Jul 24, 2023
Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa
Active, not recruiting
- Antibiotic Resistant Strain
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Mar 30, 2022
Otitis Media, Infections, Respiratory Tract, Respiratory Tract Infections Trial in India (Augmentin (ES)-600)
Completed
- Otitis Media
- +2 more
- Augmentin (ES)-600
-
Raipur, Chhattisgarh, India
- +12 more
Nov 30, 2022
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- Ceftibuten
- (no location specified)
Nov 27, 2023
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022